Precision medicine in primary biliary cholangitis-Reference-Cited by-同舟云学术

Precision medicine in primary biliary cholangitis

Published:2019-07 Issue:7 Volume:20 Page:338-345
ISSN:1751-2972
Container-title:Journal of Digestive Diseases
language:en
Short-container-title:J Dig Dis

Author:

Ronca Vincenzo¹,Gerussi Alessio¹,Cristoferi Laura¹,Carbone Marco¹,Invernizzi Pietro¹^ORCID

Affiliation:

1. Division of Gastroenterology and Center for Autoimmune Liver Diseases, San Gerardo Hospital, Department of Medicine and SurgeryUniversity of Milano—Bicocca Monza Italy

Funder

Ministero della Salute

Publisher

Wiley

Subject

Gastroenterology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1751-2980.12787

Reference44 articles.

1. Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic Acid

2. Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study

3. Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

4. The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis

5. Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Stratification in Primary Biliary Cholangitis;Journal of Clinical Medicine;2023-09-01

2. Novel Insights From Basic Science in Psoriatic Disease at the GRAPPA 2022 Annual Meeting;The Journal of Rheumatology;2023-08-01

3. Colangitis biliar primaria: caracterización de una cohorte retrospectiva;Hepatología;2022-07-05

4. Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USA;Digestive Diseases and Sciences;2021-09-09

5. Breakdown in hepatic tolerance and its relation to autoimmune liver diseases;Minerva Gastroenterology;2021-04